Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
4
×
clinical trials
detroit blog main
detroit top stories
eli lilly
glaxosmithkline
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
bristol-myers squibb
deals
fda
merck
abbvie
aduro biotech
allergan
What
bio
roundup
4
×
black
companies
diamond’s
alliance
appetite
approval
biogen’s
biopharmaceutical
bread
bristol
butter
buy
buyout
calls
cancer
cash
changing
color
continue
convo
crispr
days
debut
diabetes
diamond
drug
drugs
earlier
eli
failures
giant
grabbed
growing
hasn’t
hold
hours
indication
kudos
Language
unset
Current search:
glaxosmithkline
×
startups
×
roundup
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More